Joel Greenblatt started to build up the position in Organogenesis Holdings in Q3 2021 and continued to invest until Q4 2021. Since then they sold 35.9 Thousand shares. The investor completely sold their stake between Q1 2022 and Q3 2022.
Avg closing price
Price range
Sold -11.9 Thousand shares
Q3 2022
Avg closing price
$4.52
Price range
$3.14
-
$6.43
Sold 65.6% shares (-22.7 Thousand shares)
Q2 2022
Avg closing price
$6.16
Price range
$4.74
-
$8.15
Sold 3.9% shares (-1.39 Thousand shares)
Q1 2022
Avg closing price
$7.74
Price range
$6.47
-
$9.57
Increased shares by 74.8% (+15.4 Thousand shares)
Q4 2021